281 related articles for article (PubMed ID: 27373929)
21. Administration of branched-chain amino acids alters epigenetic regulatory enzymes in an animal model of Maple Syrup Urine Disease.
Streck EL; Bussular FP; Wessler LB; Duarte MB; Rezende VL; Rodrigues MS; Torres CA; Lemos IS; Candiotto G; Gava FF; de Oliveira J; Valvassori SS
Metab Brain Dis; 2021 Feb; 36(2):247-254. PubMed ID: 33098071
[TBL] [Abstract][Full Text] [Related]
22. Adipose transplant for inborn errors of branched chain amino acid metabolism in mice.
Zimmerman HA; Olson KC; Chen G; Lynch CJ
Mol Genet Metab; 2013 Aug; 109(4):345-53. PubMed ID: 23800641
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis of MSUD by newborn screening allows early intervention without extraneous detoxification.
Heldt K; Schwahn B; Marquardt I; Grotzke M; Wendel U
Mol Genet Metab; 2005 Apr; 84(4):313-6. PubMed ID: 15781191
[TBL] [Abstract][Full Text] [Related]
24. Branched-chain amino acid metabolism is regulated by ERRα in primary human myotubes and is further impaired by glucose loading in type 2 diabetes.
Sjögren RJO; Rizo-Roca D; Chibalin AV; Chorell E; Furrer R; Katayama S; Harada J; Karlsson HKR; Handschin C; Moritz T; Krook A; Näslund E; Zierath JR
Diabetologia; 2021 Sep; 64(9):2077-2091. PubMed ID: 34131782
[TBL] [Abstract][Full Text] [Related]
25. Morphological alterations and induction of oxidative stress in glial cells caused by the branched-chain alpha-keto acids accumulating in maple syrup urine disease.
Funchal C; Latini A; Jacques-Silva MC; Dos Santos AQ; Buzin L; Gottfried C; Wajner M; Pessoa-Pureur R
Neurochem Int; 2006 Dec; 49(7):640-50. PubMed ID: 16822590
[TBL] [Abstract][Full Text] [Related]
26. The metabolic effect of α-ketoisocaproic acid: in vivo and in vitro studies.
Farias HR; Gabriel JR; Cecconi ML; Lemos IS; de Rezende VL; Wessler LB; Duarte MB; Scaini G; de Oliveira J; Streck EL
Metab Brain Dis; 2021 Jan; 36(1):185-192. PubMed ID: 33034842
[TBL] [Abstract][Full Text] [Related]
27. Creatine and antioxidant treatment prevent the inhibition of creatine kinase activity and the morphological alterations of C6 glioma cells induced by the branched-chain alpha-keto acids accumulating in maple syrup urine disease.
Funchal C; Schuck PF; Santos AQ; Jacques-Silva MC; Gottfried C; Pessoa-Pureur R; Wajner M
Cell Mol Neurobiol; 2006 Feb; 26(1):67-79. PubMed ID: 16633902
[TBL] [Abstract][Full Text] [Related]
28. [Clinical characteristics and analysis of mass spectrometric data in 33 patients with maple syrup urine disease].
Yang N; Han LS; Ye J; Qiu WJ; Zhang HW; Gao XL; Wang Y; Li XY; Xu H; Gu XF
Zhonghua Yi Xue Za Zhi; 2012 Oct; 92(40):2839-42. PubMed ID: 23290213
[TBL] [Abstract][Full Text] [Related]
29. Primary human fibroblasts from a maple syrup urine disease patient undergo apoptosis following exposure to physiological concentrations of branched chain amino acids.
Jouvet P; Kozma M; Mehmet H
Ann N Y Acad Sci; 2000; 926():116-21. PubMed ID: 11193026
[TBL] [Abstract][Full Text] [Related]
30. Branched chain amino acids induce apoptosis in neural cells without mitochondrial membrane depolarization or cytochrome c release: implications for neurological impairment associated with maple syrup urine disease.
Jouvet P; Rustin P; Taylor DL; Pocock JM; Felderhoff-Mueser U; Mazarakis ND; Sarraf C; Joashi U; Kozma M; Greenwood K; Edwards AD; Mehmet H
Mol Biol Cell; 2000 May; 11(5):1919-32. PubMed ID: 10793161
[TBL] [Abstract][Full Text] [Related]
31. Alpha-ketoisocaproic acid and leucine provoke mitochondrial bioenergetic dysfunction in rat brain.
Amaral AU; Leipnitz G; Fernandes CG; Seminotti B; Schuck PF; Wajner M
Brain Res; 2010 Apr; 1324():75-84. PubMed ID: 20153737
[TBL] [Abstract][Full Text] [Related]
32. Maple syrup urine disease: analysis of branched chain ketoacid decarboxylation in cultured fibroblasts.
Wendel U; Wentrup H; Rüdiger HW
Pediatr Res; 1975 Sep; 9(9):709-17. PubMed ID: 1202420
[TBL] [Abstract][Full Text] [Related]
33. Treatment of maple syrup urine disease: Benefits, risks, and challenges of liver transplantation.
Deon M; Guerreiro G; Girardi J; Ribas G; Vargas CR
Int J Dev Neurosci; 2023 Oct; 83(6):489-504. PubMed ID: 37340513
[TBL] [Abstract][Full Text] [Related]
34. Expanding the genetic and phenotypic spectrum of branched-chain amino acid transferase 2 deficiency.
Knerr I; Colombo R; Urquhart J; Morais A; Merinero B; Oyarzabal A; Pérez B; Jones SA; Perveen R; Preece MA; Rogers Y; Treacy EP; Mayne P; Zampino G; MacKinnon S; Wassmer E; Yue WW; Robinson I; Rodríguez-Pombo P; Olpin SE; Banka S
J Inherit Metab Dis; 2019 Sep; 42(5):809-817. PubMed ID: 31177572
[TBL] [Abstract][Full Text] [Related]
35. Effect of metformin on myotube BCAA catabolism.
Rivera ME; Lyon ES; Vaughan RA
J Cell Biochem; 2020 Jan; 121(1):816-827. PubMed ID: 31385363
[TBL] [Abstract][Full Text] [Related]
36. Evidence that the branched-chain alpha-keto acids accumulating in maple syrup urine disease induce morphological alterations and death in cultured astrocytes from rat cerebral cortex.
Funchal C; Gottfried C; De Almeida LM; Wajner M; Pessoa-Pureur R
Glia; 2004 Nov; 48(3):230-40. PubMed ID: 15390119
[TBL] [Abstract][Full Text] [Related]
37. Metabolism of branched-chain amino acids in starved rats: the role of hepatic tissue.
Holecek M; Sprongl L; Tilser I
Physiol Res; 2001; 50(1):25-33. PubMed ID: 11300224
[TBL] [Abstract][Full Text] [Related]
38. Branched-chain α-ketoacid dehydrogenase deficiency (maple syrup urine disease): Treatment, biomarkers, and outcomes.
Strauss KA; Carson VJ; Soltys K; Young ME; Bowser LE; Puffenberger EG; Brigatti KW; Williams KB; Robinson DL; Hendrickson C; Beiler K; Taylor CM; Haas-Givler B; Chopko S; Hailey J; Muelly ER; Shellmer DA; Radcliff Z; Rodrigues A; Loeven K; Heaps AD; Mazariegos GV; Morton DH
Mol Genet Metab; 2020 Mar; 129(3):193-206. PubMed ID: 31980395
[TBL] [Abstract][Full Text] [Related]
39. Apoptotic signaling pathways induced by acute administration of branched-chain amino acids in an animal model of maple syrup urine disease.
Vilela TC; Scaini G; Furlanetto CB; Pasquali MA; Santos JP; Gelain DP; Moreira JC; Schuck PF; Ferreira GC; Streck EL
Metab Brain Dis; 2017 Feb; 32(1):115-122. PubMed ID: 27510712
[TBL] [Abstract][Full Text] [Related]
40. Oral enzyme therapy for maple syrup urine disease (MSUD) suppresses plasma leucine levels in intermediate MSUD mice and healthy nonhuman primates.
Skvorak K; Liu J; Kruse N; Mehmood R; Das S; Jenne S; Chng C; Lao UL; Duan D; Asfaha J; Du F; Teadt L; Sero A; Ching C; Riggins J; Pope L; Yan P; Mashiana H; Ismaili MHA; McCluskie K; Huisman G; Silverman AP
J Inherit Metab Dis; 2023 Nov; 46(6):1089-1103. PubMed ID: 37494004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
